Sven Rudolf Kreutel's Biography

Sven Rudolf Kreutel, Chief Executive Officer, Particle Metrix GmbH and CEO, Particle Metrix Inc., USA

Sven Kreutel studied biology at the University of Hohenheim in Stuttgart, Germany. After his graduation in biology, he received his PhD in microbiology and protein biochemistry at the University of Hohenheim under Prof. Dr. Andreas Kuhn and Dr. Dorothee Kiefer working on the light sensing and signal transduction in photosynthetic bacteria. Since then he worked in different sales and sales manager positions within the life science industry from clinical research over biology to nanoparticle sciences. In 2021 he was appointed as CEO of the American subsidiary of Particle Metrix.

Colocalization of Biomarkers with the New Particle Metrix ZetaView x30 Family

Monday, 13 November 2023 at 14:00

Add to Calendar ▼2023-11-13 14:00:002023-11-13 15:00:00Europe/LondonColocalization of Biomarkers with the New Particle Metrix ZetaView x30 FamilyExtracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

During the last decades, Nanoparticle Tracking Analysis (NTA) has emerged as a vital and fast characterization technology for biological nanoparticles like Extracellular Vesicles (EVs), Exosomes and Viruses. While classic NTA scatter operation feeds back particle size and total concentration, the fluorescence detection capability (f-NTA) enables the user to gain specific biochemical information. Statistical determination of signal colocalization on low nano scale particles however, is a challenging task for any analytical instrument including flow cytometers and microscopes. A new laser generation paired with ultra fast switching times between fluorescence channels lays the foundation of colocalization nanoparticle tracking analysis (C-NTA) introduced recently by Particle Metrix. For the first time, we report results of colocalization measurements on reference material as well as real biological nanoparticles based on NTA technology on the new ZetaView® PMX-430 QUATT.

Add to Calendar ▼2023-11-13 00:00:002023-11-14 00:00:00Europe/LondonExtracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023Extracellular Vesicles and Nanoparticle-based Therapeutics Europe 2023 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors